Company news
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) news
Ekso Bionics Holdings, Inc. news releases on 6ix. Latest, May 6, 2026: ChronoScale Appoints Cenly Chen as Chief Executive Officer to Lead Next Phase of AI…
Press releases & updates
ChronoScale Appoints Cenly Chen as Chief Executive Officer to Lead Next Phase of AI Compute Growth
May 6, 2026
Applied Digital Completes Separation of Cloud Business, Establishing ChronoScale as Independent Public Company
May 5, 2026
Ekso Bionics Prices $5.852 million Private Placement
January 21, 2026
Applied Digital Reports Fiscal Second Quarter 2026 Results
January 7, 2026
Applied Digital to Spin Out Cloud Business, Proposes Business Combination with EKSO to Launch ChronoScale
December 28, 2025
Ekso Bionics Inks Agreement to Become the Exclusive U.S. Distributor of MediTouch’s Groundbreaking BalanceTutor™ Rehabilitation System
December 4, 2025
Ekso Bionics Announces $3.7 Million Registered Direct Offering of Common Stock Priced At-the-Market under Nasdaq Rules
October 29, 2025
Ekso Bionics Reports Third Quarter 2025 Financial Results
October 28, 2025
Ekso Bionics Reports Second Quarter 2025 Financial Results
July 28, 2025
Ekso Bionics to Report Second Quarter 2025 Financial Results on July 28 – Conference Call to Follow
July 21, 2025
Virtual eksoUniversity to Support Continuing Education of PTs and PTAs Across the Country
July 18, 2025
Ekso Bionics’ Acceptance into NVIDIA Connect Program Bears Early Fruit
June 18, 2025
Ekso Bionics Announces New Effective Date of Reverse Stock Split
May 21, 2025
Ekso Bionics Announces Reverse Stock Split
May 19, 2025
Ekso Bionics Accepted into NVIDIA Connect Program
May 15, 2025
Ekso Bionics Reports First Quarter 2025 Financial Results
May 5, 2025
Ekso Bionics to Report First Quarter 2025 Financial Results on May 5 – Conference Call to Follow
April 28, 2025
Bionic P&O Chosen as First Distributor of Ekso Indego® Personal Within the Orthotics & Prosthetics Industry
April 23, 2025
Ekso Bionics Reports Fourth Quarter and Full-Year 2024 Financial Results
March 3, 2025
Ekso Bionics to Report Fourth Quarter and Full Year 2024 Financial Results on March 3 – Conference Call to Follow
February 24, 2025
NSM Named Exclusive Distributor of Ekso Indego® Personal Within the CRT Industry
February 9, 2025
Ekso Bionics Reports Certain Preliminary Fourth Quarter 2024 Financial Results
January 12, 2025
Ekso Bionics to Showcase Its Device Technology in ‘AI for Good’ Webinar on Tuesday, November 19
November 17, 2024
Ekso Bionics to Participate at the 15th Annual Craig-Hallum Alpha Select Conference
November 11, 2024
Ekso Bionics Announces Third Quarter 2024 Financial Results
October 27, 2024
Ekso Bionics to Report Third Quarter 2024 Financial Results on October 28, 2024
October 20, 2024
Ekso Bionics Announces Pricing of $6.0 Million Underwritten Public Offering
August 28, 2024
Ekso Bionics Announces Receipt of Initial CMS Reimbursement for Ekso Indego Personal
August 19, 2024
Ekso Bionics Reports Record Quarterly Sales of $5.0 Million in Second Quarter 2024
July 28, 2024
Ekso Bionics to Report Second Quarter 2024 Financial Results on July 29, 2024
July 21, 2024
Ekso Bionics Announces Research Partnership with Shepherd Center
June 24, 2024
Ekso Bionics Appoints Deborah Lafer Scher to its Board of Directors
June 16, 2024
Ekso Indego Personal to be Featured on ‘Health Uncensored’ with Dr. Drew Pinsky
May 9, 2024
Ekso Bionics Announces First Quarter 2024 Financial Results
April 28, 2024
Ekso Bionics to Report First Quarter 2024 Financial Results on April 29, 2024
April 21, 2024
Ekso Bionics Receives Final Payment Determination for Medicare Reimbursement from the Centers for Medicare & Medicaid Services (CMS) for Ekso Indego Personal
April 11, 2024
Ekso Bionics Reports Record Annual Revenue of $18.3 Million
March 3, 2024
Ekso Bionics to Report Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024
February 25, 2024
Ekso Bionics Announces $4.6 Million Registered Direct Offering
January 10, 2024
Ekso Bionics Launches GaitCoach Software for EksoNR
January 7, 2024
Ekso Bionics Reports Certain Preliminary Fourth Quarter and Full Year 2023 Financial Results
January 3, 2024
Ekso Bionics Receives CMS Coding Approval for Ekso Indego Personal
December 11, 2023
Ekso Bionics to Participate at Centers for Medicare & Medicaid Services (CMS) Second Biannual 2023 Healthcare Common Procedure Coding System (HCPCS) Public Meeting on Wednesday, November 29
November 15, 2023
Centers for Medicare & Medicaid Services (CMS) Codifies Medicare Coverage for Ekso Indego Personal
November 1, 2023
Ekso Bionics Reports Third Quarter 2023 Revenue Growth of 38%
October 25, 2023
Ekso Bionics to Report Third Quarter 2023 Financial Results on October 26, 2023
October 18, 2023
Ekso Bionics Supports Centers for Medicare & Medicaid Services (CMS) Proposed Rule to Include Personal Exoskeletons within a Medicare Benefit Category
September 26, 2023
Ekso Bionics to Participate at the H.C. Wainwright 25th Annual Global Investment Conference
September 10, 2023
Ekso Bionics Reports Record Revenues of $4.7 Million in Second Quarter 2023
July 26, 2023
Ekso Bionics to Report Second Quarter 2023 Financial Results on July 27, 2023
July 19, 2023